Market Research Report
Antivirals Market Analysis: By Type (Hepatitis-C, HIV, Herpes, Hepatitis-B, Influenza & Other Antivirals); By Action (DNA polymerase inhibitors, NS3 Protease inhibitors, Reverse transcriptase inhibitors and Others) A- With Forecast 2019-2024
|Published by||IndustryARC||Product code||416638|
Delivery time: 2-3 business days
|Antivirals Market Analysis: By Type (Hepatitis-C, HIV, Herpes, Hepatitis-B, Influenza & Other Antivirals); By Action (DNA polymerase inhibitors, NS3 Protease inhibitors, Reverse transcriptase inhibitors and Others) A- With Forecast 2019-2024|
|Published: December 25, 2018||Content info:||
Antivirals are drugs that are used to treat viral infections. While a majority of antivirals are used for treating specific viral infections, there are a few broad-spectrum antivirals to treat other viral infections. As opposed to antibiotics that actually destroy the target pathogen, antivirals only inhibit the growth of the pathogen. Antivirals have the advantage of not causing any side effects and focus on inibiting the replication of the virus. An increase in the disease afflicted population across the globe is one of the major drivers for this market. Apart from this, increasing levels of awareness coupled with the launch of newer and more effective drugs, this market has tremendous opportunities in emerging economies. The antiviral market is expected to grow at a steady and healthy growth rate till the end of the forecast period considered in this report. Expiry of patents is another factor providing opportunities for this market. Factors that include government policies can prove to be challenging factors in this market.
The report also provides an exhaustive overview of antiviral research and development pipeline. A huge amount of research and development is underway to extend the range of antivirals to treat other pathogens. Also, with the tendency of viruses to mutate and become drug resistant, the need of the hour is to develop and refresh the pipeline of antivirals with new therapies. A section on patent analysis is also included.
Antiviral drugs are used in the treatment of HIV, herpes viruses, the hepatitis B and C viruses, and influenza A and B viruses. The global antivirals market is expected to be dominated by HIV antivirals. According to the WHO and UNAIDS estimates, 36.7 million people were living with HIV globally at the end of 2015. In 2015, approximately 2.1 million people became newly infected and 1.1 million died of HIV-related causes.
DNA polymerase inhibitors
NS3 Protease inhibitors
Reverse transcriptase inhibitors
Merck & Co
Johnson and Johnson
Novartis International AG
Gilead Sciences Inc
More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"